Drug Trial Radar · NCT01514851
Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
Last checked: Nov 20, 2026Latest source record: Jun 8, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
259
Actual
Start
Jan 2006
Primary completion
May 2006
Study completion May 2006
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Jan 23, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the effect on reduction of serum phosphate and the safety of BAY77-1931 (Lanthanum Carbonate) in patients with hyperphosphatemia undergoing hemodialysis in a randomized, double-blind, parallel group study in comparison with Calcium carbonate.
Conditions
- Hyperphosphatemia
Interventions
Lanthanum carbonate (BAY77-1931)Drug
Calcium carbonateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in pre-dialysis serum phosphate levels (PSPL) at the end of the double-blind periodTime frame: baseline to week 8
- Presence/absence of incidence of hypercalcemia up to 8 weeksTime frame: up to 8 weeks
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Toyohashi, Aichi-ken, Japan
Site not named
Yatomi, Aichi-ken, Japan
Site not named
Asahi, Chiba, Japan
Site not named
Chiba, Chiba, Japan
Site not named
Kashiwa, Chiba, Japan
Site not named
Matsudo, Chiba, Japan
Site not named
Narita, Chiba, Japan
Site not named
Kurume, Fukuoka, Japan
Site not named
Kurume, Fukuoka, Japan
Site not named
Isesaki, Gunma, Japan
Site not named
Hiroshima, Hiroshima, Japan
Site not named
Kobe, Hyōgo, Japan
Site not named
Mito, Ibaraki, Japan
Site not named
Tsuchiura, Ibaraki, Japan
Site not named
Takamatsu, Kagawa-ken, Japan
Site not named
Kochi, Kochi, Japan
Site not named
Ōsaki, Miyagi, Japan
Site not named
Sendai, Miyagi, Japan
Site not named
Okayama, Okayama-ken, Japan
Site not named
Suita, Osaka, Japan
Site not named
Saitama, Saitama, Japan
Site not named
Saitama, Saitama, Japan
Site not named
Saitama, Saitama, Japan
Site not named
Fuji, Shizuoka, Japan
Site not named
Hamamatsu, Shizuoka, Japan
Site not named
Tokushima, Tokushima, Japan
Site not named
Arakawa-ku, Tokyo, Japan
Site not named
Kodaira, Tokyo, Japan
Site not named
Nerima-ku, Tokyo, Japan
Site not named
Shibuya-ku, Tokyo, Japan
Site not named
Shinjyuku-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.